Navigation Links
Novartis receives FDA approval of Tekamlo™, a single-pill combination of aliskiren and amlodipine to treat high blood pressure
Date:8/27/2010

gement, offering a range of innovative therapies designed to help patients with different needs achieve their blood pressure goals. Novartis is dedicated to helping physicians and patients improve cardiovascular and metabolic health through effective medicines, programs and an ongoing commitment to research.

Tekamlo is available in four strengths as once-daily tablets containing aliskiren and amlodipine:  150 mg/5 mg tablets, 150 mg/10 mg tablets, 300 mg/5 mg tablets and 300 mg/10 mg tablets.  

About TekamloTekamlo is indicated for the treatment of hypertension, alone or with other antihypertensive agents.

Use Tekamlo as initial therapy in patients who are likely to need multiple drugs to achieve their blood pressure goals. Base the choice of Tekamlo as initial therapy on an assessment of potential benefits and risks. Individualize the decision to use a combination as initial therapy by weighing factors such as baseline blood pressure, the target goal, and the incremental likelihood of achieving goal with a combination compared to monotherapy.

Switch a patient whose blood pressure is not adequately controlled with aliskiren or amlodipine (or another dihydropyridine calcium channel blocker) alone to combination therapy with Tekamlo.

Important ConsiderationsWARNING: AVOID USE IN PREGNANCYWhen pregnancy is detected, discontinue Tekamlo as soon as possible.  Drugs that act directly on the renin-angiotensin-aldosterone system can cause injury and even death to the developing fetus. [See WARNINGS and Precautions (5.1) and Use in Special Populations (8.1) in full Prescribing Information]Angioedema of the face, extremities, lips, tongue, glottis, and/or larynx has been reported in patients treated with aliskiren and has necessitated hospitalization and intubation. This may occur at any time during treatment and has occurred in patients with and without a history of angioedema with ACE inhibitors (ACEI) or angiotensin
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
3. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
4. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
5. More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
6. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
7. Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
8. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
9. Results In The New England Journal Of Medicine Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
10. Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
11. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014 The American Association ... Medical Design and Manufacturing has joined the AAHomecare Corporate ... Harvey Diamond have been actively involved in ... as it has quickly grown into a major global ... like Drive allows AAHomecare to increase efforts on behalf ...
(Date:9/19/2014)... 19, 2014 According to ... (Benchtop, Mobile, Industrial, & Laboratory), Industry (Food, Pharmaceutical, ... & Rotary) & Geography - Global Trends & ... segments the lyophilization market on the basis of ... projections of the market size of each of ...
(Date:9/19/2014)... and ORLANDO, Fla. , Sept. ... Inspire therapy continues to grow, with the publication of ... on-line in Otolaryngology – Head and Neck ... a worsening of both objective and subjective measures of ... attribute Inspire therapy for the reduction in obstructive sleep ...
Breaking Medicine Technology:Drive Medical Design & Manufacturing Joins AAHomecare Corporate Partner Program 2Lyophilization Market Worth $5,121.5 Million by 2019 2Lyophilization Market Worth $5,121.5 Million by 2019 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 2New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 4
... , SAN DIEGO , July 14 ... the Marketing Authorization Application (MAA) for OraVerse has been accepted ... Kingdom (UK), Germany , Italy , ... and only local anesthesia reversal agent that accelerates the return ...
... 13 Program officials have confirmed that they will announce the ... conference tomorrow in Atlanta .  Georgia Drug Card is being launched ... medications. , , , ... obtain prescription cards at various hospitals, clinics, and other card distribution sites ...
Cached Medicine Technology:Sanofi-Aventis and Novalar File Marketing Authorization Application for OraVerse® in Five Key European Countries 2Sanofi-Aventis and Novalar File Marketing Authorization Application for OraVerse® in Five Key European Countries 3Sanofi-Aventis and Novalar File Marketing Authorization Application for OraVerse® in Five Key European Countries 4
(Date:9/21/2014)... new study of cancer patients who smoke, those using ... dependent and equally or less likely to have quit ... Cancer , a peer-reviewed journal of the American ... benefits of e-cigarettes for helping cancer patients give up ... all cancer patients who smoke should be advised to ...
(Date:9/21/2014)... UNIWIGS, one of the leading online stores of ... offers a line of human hair lace wigs inspired by ... shows people what the latest celebrity hairstyles are. ... are 4 different hairstyles to choose from: a style of ... wigs and a hot ombre red lace wig. People can ...
(Date:9/21/2014)... September 21, 2014 Hastings and Hastings, ... announces record demand for aggressively discounted accident victim attorney’s ... throughout the Valley each year, it is more important ... to discounted attorney’s fees as a way to enjoy ... Hastings has been a frontrunner when it comes to ...
(Date:9/21/2014)... 2014 More than a quarter of house ... start in one of two ways. The first type of ... The second type of dryer fire occurs when lint builds ... also catch fire due to malfunctioning electrical systems so if it ... a look!) Here are some ways that you can prevent ...
(Date:9/21/2014)... trigger an allergy to peanuts than raw peanuts, suggests ... say that specific chemical changes caused by the high ... the body,s immune system, ,priming, the body to set ... sees any peanuts. , The results might explain the ... in the Western world compared to populations in East ...
Breaking Medicine News(10 mins):Health News:E-cigarettes unhelpful in smoking cessation among cancer patients 2Health News:UniWigs New Arrivals Just In- Human Hair Lace Wigs Inspired By Famous Celebrities 2Health News:Hastings & Hastings Announces Record Demand For Aggressively Discounted Accident Victim Attorney’s Fees 2Health News:Hastings & Hastings Announces Record Demand For Aggressively Discounted Accident Victim Attorney’s Fees 3Health News:Restoration Local Offers Tips to Avoid Dryer Fires 2Health News:Restoration Local Offers Tips to Avoid Dryer Fires 3Health News:Dry roasting could help trigger peanut allergy 2
... Scottish ministers have announced a ?4 million cash boost to fight ... cash is expected to go towards stemming Scotland's high rates of ... sufferers. ,It has been estimated that about 20,000 people ... to be a "silent killer" among Scotland's drug users - in ...
... from the University of Newcastle, UK, a drug used ... the damage caused in cirrhosis of the liver.// ... scarring linked with cirrhosis is irreversible, the recent study ... by using Sulphasalazine.,Heavy drinking and obesity has resulted in ...
... reliable tests to detect early stages of cancerous growth in ... colon cancers successfully//, is often a procedure associated with a ... by going through this procedure to rule out or confirm ... fear of the discomfort they may have to go through. ...
... the young, so all anti-binge drinking sermons are by default ... fence//, it has come to light that the fifty and ... of drinks, to the extent of causing irreparable damage to ... can cause damage to the liver and brain. ...
... A new study says that uterine cancer is more lethal ... found that black women// with uterine cancer survived for 10.2 ... the same treatment. ,Dr. G. Larry Maxwell and his ... said black women were 26 percent more likely to die ...
... those who feel low during these nine months should seek ... Tommy's Baby Charity here surveyed 1,000 women about how they ... ,The survey found that three in five women ... Two thirds felt even more exhausted than they expected and ...
Cached Medicine News:Health News:Scotland’s Fight against Hepatitis C Boosted by ? 2
The Doro Halo retractor system is designed for all neurosurgical applications where retraction of the brain tissue and an armrest is required....
Molt 9, excellent for subperiosteal tunneling....
Love-Adson periosteal elevator, semi sharp, blade width 3/16" (5 mm), length 6 1/2" (165 mm)....
Iowa University periosteal elevator, blade width 11/16" (17 mm), length 7 1/4" (184 mm)....
Medicine Products: